What are the requirements for your specific business? Will the system be compatible with your existing hardware and software? How user friendly is the interface? These are just a few of the questions you'll need to answer before making a decision to switch to an electronic batch recording system


What are the requirements for your specific business? Will the system be compatible with your existing hardware and software? How user friendly is the interface? These are just a few of the questions you'll need to answer before making a decision to switch to an electronic batch recording system.

Here is a list of the factors to consider before making that decision.

### Scalable to support growth

The electronic batch record system should be scalable to support growth. Making sure the chosen system is able to handle multiple users, has a user-friendly interface, and can generate reports quickly and easily. And if expanding into new markets, making sure the system is able to accommodate different languages and currencies is important.

### Configurable to support changing business needs

As the business grows and changes, the batch record system must grow and change. That's why it's important to choose a system that's configurable—so it can be adapted to specific needs.

The system should be able to capture all the data, from production through shipping. Most importantly, it should be reliable with reliable batch records.

### Real-time data capture and analysis

Capturing data in real-time is vital to be able to track the progress of the batches and make sure that they're staying on schedule.

A system that provides analysis and reporting functionality is useful to be able to identify any potential problems early on and fix them before they become a bigger issue.

### Track and trace capabilities

When it comes to finding the right electronic batch record system for the business, track and trace capabilities should be near the top of the list. Being able to quickly and easily track product batches is essential for quality control and safeguarding against any potential product recalls.

This also means tracking where each batch came from, who made it, what ingredients were used, and how it was processed. This information is essential for ensuring compliance with all relevant safety regulations.

### Top tips

When looking for a quality electronic batch record system, there are a few key factors to keep in mind. Here are five of the most important:

1. **Usability**: The system should be easy to use and navigate, so batch data can quickly and easily tracked.
2. **Flexibility**: The system should be able to grow with the business, easily integrating new features and accommodating changes.
3. **Accuracy**: The system should be extremely accurate, ensuring that all data is properly logged and tracked.
4. **Security**: The system must be secure, protecting data from unauthorised access or alteration.
5. **Compatibility**: The system should be compatible with existing software and hardware.

Read about Opvia’s EBR software [here](https://www.opvia.io/) and sign up for a demo [here](https://www.opvia.io/contact).


Food & Beverage

Pharmaceutical

What to look for in an electronic batch record system?

Electronic batch records are software programs designed to track the progress of each individual product throughout its lifecycle


Electronic batch records are software programs designed to track the progress of each individual product throughout its lifecycle. These systems allow companies to track their inventory, production, distribution, and sales data. EBR's are commonly used in pharmaceutical manufacturing.

1.  **Quality Control**: The use of EBR's helps ensure quality control standards are met throughout the entire production cycle. When using these systems, companies are able to monitor the status of each product at any given time, ensuring they are not missing any steps along the way.
2.  **Cost Savings:** In addition to tracking products throughout the production cycle, EBR's also help reduce costs. By eliminating manual processes, EBR's save money by reducing labour hours and increasing efficiency.
3.  **Data Security**: With the rise of cybercrime, many businesses are taking measures to protect themselves from identity theft. Using an EBR system means the company data is protected from unauthorised access to sensitive information.
4.  **Productivity**: Another benefit of using an EBR system is increased productivity. Since EBR automates repetitive tasks, employees are free to focus on higher value activities.

Opvia’s no-code EBR solution is a simple yet effective solution that can be made to fit for various manufacturing processes in the pharmaceutical industry. Read more about Opvia’s solution  and sign up for a demo [here](https://www.opvia.io/contact).


Drug development - 4 reasons pharmaceuticals need an EBR system.

AI can help identify inefficiencies in manufacturing processes and suggest ways to optimise them


AI can help identify inefficiencies in manufacturing processes and suggest ways to optimise them. AI can also be used to monitor production data and make predictions about future outcomes.

Electronic batch records play a key role in facilitating the implementation of AI techniques.

Here's how it works: the electronic batch record is used to capture all the data related to the manufacturing process, from raw materials to the finished product. This data is then analysed by AI software, which can identify patterns and trends that would otherwise be missed. This information can then be used to improve the manufacturing process, making it more efficient and productive.

### How electronic batch records can be used to facilitate the implementation of machine learning algorithms

Electronic batch records can play a crucial role in the implementation of machine learning algorithms in the manufacturing process.

Machine learning algorithms need large data sets in order to be effective. Electronic batch records provide a comprehensive history of all the batches that have been produced, which can be used to train the machine learning algorithm.

The electronic batch record also contains information about the recipe that was used to produce the batch, and this information can be used to verify that the machine learning algorithm is producing accurate results.

### The benefits of using electronic batch records to implement AI techniques

1. **Accuracy**: When data is entered into an electronic batch record, it's immediately validated for accuracy. This means that there's no margin for human error, which can lead to mistakes in the manufacturing process.
2. **Traceability**: Electronic batch records create a paper trail that can be traced back to the source. This is helpful for troubleshooting and quality control purposes.
3. **Efficiency**: With electronic batch records, manufacturers can track production data in real-time. This allows them to respond quickly to any issues that may arise and make necessary adjustments.
4. **Insight**: By analysing production data, manufacturers can gain valuable insights into their manufacturing processes. This helps them to identify areas where they can make improvements and optimise their operations.

### The future of electronic batch records and AI-enabled manufacturing processes

Electronic batch records play a key role in ensuring the accuracy and consistency of data during the manufacturing process. They also provide a record of the manufacturing process, which can be used to verify that the product meets the required specifications.

But that's just the beginning. In a future where AI techniques are used in manufacturing processes, Electronic batch records will become even more important. They will be essential for ensuring that the data is processed correctly and that the products meet the required standards.

By maintaining an accurate and up-to-date record of all the batches that have been produced, electronic batch records make it possible to identify any changes or deviations in the manufacturing process. This can then be used as the basis for training and deploying AI models. But that's not all; electronic batch records can also play a role in verifying the accuracy of the predictions made by those AI models. In other words, they can help to ensure that the decisions made by AI-enabled systems are trustworthy and reliable. Read about Opvia’s EBR software [here](https://www.opvia.io/) and sign up for a demo [here](https://www.opvia.io/contact).


How electronic batch records facilitate the implementation of AI techniques

When it comes to developing active pharmaceutical ingredients (APIs), efficiency and reliability are key


When it comes to developing active pharmaceutical ingredients (APIs), efficiency and reliability are key. That's where an electronic batch record comes in.

An electronic batch record can help you streamline your API development process and ensure accuracy and compliance.

### Process of active pharmaceutical ingredient development

An electronic batch record is a digital system that helps you track and document every step of the API development process. It's a great way to ensure that all the ingredients are mixed together in the right proportions, and that the finished product meets all the relevant quality standards.

Using an electronic batch record can also help you speed up the approvals process, since providing regulators with all the documentation they need is easier. With regards to selling the product, an EBR can prove to buyers that your product is of the highest quality.

### Benefits of using an EBR

Electronic batch records have a lot of benefits when it comes to active pharmaceutical ingredient (API) development.

For starters, they help keep track of all the stages of the development process. Every step is recorded, from the initial formulation to the final product. This level of detail is essential for ensuring that the product is safe and compliant with all regulatory standards.

But electronic batch records don't just help you keep track of what's happening; they also help you optimize your operations. By automating many of the tasks that are traditionally done by hand, time and money is saved whilst maintaining consistent data.

Some of the benefits include:

- An electronic batch record can help you keep track of all the steps in the development process. This way, one can be sure that everything is being done correctly and that all the necessary safety measures are in place.
- It also makes it easier to share information with teams. With everyone having access to the same information, there's less chance for confusion or miscommunication.
- An electronic batch record can help save time and money. By streamlining the development process, the amount of time it takes to bring a product to market is reduced.
- EBRs track all production batches and make sure that everything is being done according to protocol. This is especially important during the development phase, when mistakes can be costly.
- It also helps with data management, QA/QC, and communication.

### Advantages of using an EBR

1. **Accuracy**: An electronic batch record ensures that all data is captured and recorded accurately, without the risk of human error.
2. **Security**: The records are stored in a secure location and can be accessed at any time.
3. **Efficiency**: The automated process eliminates the need for manual data entry, which can lead to mistakes.
4. **Traceability**: The electronic batch record can be used to trace the history of a batch of API, from beginning to end.
5. **Flexibility**: The electronic batch record can be customized to meet the specific needs of your organization.

An electronic batch record can be a huge help during the Active Pharmaceutical Ingredient Development process. By using an electronic batch record, all data is stored in one place, making it easy to access and track. This can help to reduce mistakes and speed up the development process. Read about Opvia’s [here](https://www.opvia.io/) and sign up for a demo [here](https://www.opvia.io/contact).


The API development process and how an EBR can help

The pharmaceutical industry is one of the most sensitive industries when it comes to product recalls


The pharmaceutical industry is one of the most sensitive industries when it comes to product recalls. This is because a recall can have a huge negative impact on not only the company's reputation, but also on the health of its customers.

To maintain high quality in electronic batch records (EBRs), companies need to take a number of measures. These include ensuring that all data entered into EBRs is accurate and up-to-date, ensuring that all batch records are properly tagged and filed, and monitoring production processes closely to ensure that no errors or deviations occur. If there is any potential issue with a batch of medication, it is important for the pharmaceutical company to immediately identify and correct it. This can be done through EBRs, which provide detailed information about each step of the manufacturing process.

In addition to the quality controls within the EBR system, another benefit is that it makes batch record reviews quicker and faster. Batch record reviews (BRRs) are a vital step in the pharmaceutical industry that help ensure that all quality and compliance rules are met. They're also a way to identify any potential problems with the drug product before it's released to the public.

### What are batch record reviews?

BRRs are carried out by inspectors at the level of batch, lot, or package. They check to make sure that all steps in the manufacturing process have been followed correctly and that all specifications for the drug have been met. This includes checking for any potential safety issues, verifying ingredients and quantities, and assessing whether any deviations from normal manufacturing procedures have occurred.

### How does an EBR help with BRRs?

Electronic batch records make batch record reviews (BRRs) much faster and easier. By tracking all the required data in an EBR system, BRRs can be quickly and easily performed. This means that every piece of information is available at your fingertips, making it easy to determine whether or not all quality and compliance rules have been followed.

An EBR system also makes it easy to identify any problems early on, before they become serious. This means that you can take corrective action quickly and ensure that everything is running smoothly from start to finish prior to these issues being flagged in a review.

BRRs are an important part of ensuring the quality and safety of drugs, and they play an integral role in keeping patients safe. By conducting regular reviews, pharmaceutical companies can avoid any unforeseen problems and the implementation of an EBR system facilitates this process. Read about Opvia’s EBR software  and sign up for a demo [here](https://www.opvia.io/contact).


How does an EBR help with faster batch record reviews in the pharmaceutical industry?

CAPA is a corrective and preventive action plan that's implemented in a manufacturing process to ensure the quality of the products being produced


CAPA is a corrective and preventive action plan that's implemented in a manufacturing process to ensure the quality of the products being produced.

But having a CAPA plan is just one part of the equation - having a system in place to track and record these corrective and preventive actions is vital. This is where electronic batch recording comes in.

### What is CAPA?

CAPA is short for corrective and preventive action. It's a process that helps identify and address problems before they become big issues. And it's a critical part of any manufacturing process.

But implementing a CAPA plan can be difficult, especially without the right tools. That's where an electronic batch recording system comes in. It can help track batches of product as they move through the process, so problems are quickly identified.

### How can an electronic batch recording system help CAPA planning?

The EBR system can help automate the CAPA process, making it easier and faster to identify and track any potential problems.

An electronic batch recording system can also help generate reports that document the history of each batch of product. This information can be vital in proving that the CAPA plan is effective and helping avoid any costly penalties from regulatory agencies.

### Are there any other benefits of EBR Systems?

An electronic batch recording system can be an important piece of a CAPA plan. But some other benefits of an EBR system are:

- Real-time updates on the manufacturing process, so less time spent on investigating issues and more time fixing them.
- All data will be in one place, running reports is quicker and easier, without having to spend hours compiling information from different sources.

When it comes to ensuring the quality of products, having a corrective and preventive action (CAPA) plan is essential. An electronic batch recording system can help track the history of every product, from production through delivery. This information can be used to evaluate and improve a CAPA plan. Read about Opvia’s EBR software [here](https://www.opvia.io/) and sign up for a demo [here](https://www.opvia.io/contact).


CDMO

How an electronic batch recording system helps with CAPA planning

Electronic batch records (EBRs) are digital records of all the data regarding the drug's development


Electronic batch records (EBRs) are digital records of all the data regarding the drug's development. They can be used to track everything from the ingredients used in a drug to the manufacturing process itself.

This is important because it allows for better quality control and accountability throughout the entire drug development process. It also makes it easier to track adverse effects, as well as any problems that may occur during manufacturing or shipping. In short, EBRs play an essential role in ensuring that drugs are safe and effective when they hit the market.

### What are medical DHRs?

Medical device history records are similar yet the information they track are different. Medical device history records typically contain more detailed information than electronic batch records, such as manufacturing and testing dates, personnel involved, and so on. This includes:

- Information about changes or modifications to a product's specifications or design.
- How was the product designed?
- Who developed the product?
- Where was the product manufactured?
- What tests were performed on the product?

### What is the difference between the two?

Apart from the information that both an EBR and a DHR tracks, both also act at different stages of the medical device lifecycle. An EBR records all the product data prior to manufacturing while a DHR is a production history for a medical device.

Both records have different purposes but require the collection of data throughout the development and manufacturing of the medical device. These records help ensure compliance with regulatory requirements, as well as safety and efficacy of devices. It also allows for traceability of devices throughout the lifecycle, from research to distribution, and ultimately use. Implementation of a MES software that can effectively collect and store relevant information can make the process of EBR and DHR creation easier and faster. Read about Opvia’s EBR software  and sign up for a demo [here](https://www.opvia.io/contact).


Difference between an electronic batch record and a medical device history record in the pharmaceutical industry?

Quality of records is extremely important when making the switch from manual to electronic batch records


Quality of records is extremely important when making the switch from manual to electronic batch records. EBR can help you maintain a detailed record of all data regarding a batch production, which will make it easier for you to track and trace defective products. This way, you can quickly and easily identify the source of the problem and take appropriate action to address it. In addition, complying with regulatory requirements is vital for the product to be validated and brought to the market.

The Food and Drug Administration (FDA) has specific regulations that must be followed when it comes to electronic batch records (EBR). These EBR regulations were put in place to ensure that all data related to a batch production is properly documented and tracked.

### EBR requirements include the following:

- All data must be captured in a manner that is easily retrievable and can be verified.
- All data must be accurate and complete at all times.
- The data must be stored in a secure location, accessible only by authorised personnel.
- The data must be regularly updated and maintained.
- Records must be kept for a period of five years
- Records must be updated whenever there are changes or deviations from the original recipe or batch plan.

### The specific regulations to comply with depend o the industry on the product:

- **21 CFR Part 211**: Details the regulations for record keeping in the pharmaceutical industry
- **21 CFR Part 820**: Details the regulations for record keeping in the medical device sector.
- **21 CFR Part 111**: Details the requirements for medical nutrition and dietary supplements

The purpose of electronic batch records is to ensure that all data related to a given production is documented and tracked in an organised manner. This allows for better quality control and ensures that any problems that may occur during the production process are immediately identified and addressed.Read about Opvia’s EBR software  and sign up for a demo [here](https://www.opvia.io/contact).


What are the FDA regulations to comply with for EBRs?

Bioprocesses are complex and require high qualoty standards that must be managed and controlled efficiently


Bioprocesses are complex and require high qualoty standards that must be managed and controlled efficiently. EBRs are a great option are offer many advantages including:

- Speed up the process
- Improve accuracy and compliance
- Makes data entry easier
- Reduction in time it takes to produce reports

With the right software in place, you can streamline the batch record process and make it more efficient than ever before.

### How to implement an EBR?

There are a few key things to keep in mind when implementing an electronic batch record system in a biotech company.

1. **Work with the right software vendor**: Make sure to work with a vendor that is knowledgeable about the specific regulations and compliance requirements for the biotech industry. They should also be able to provide a system that is easy to use and navigate, so that your team can effectively manage your batches using the electronic records.
2. **Train your team**: Once you have the system in place, it's important to train your team on how to use it.
3. **Be prepared for a learning curve**: Change doesn't always come easy, and there may be a bit of a learning curve as everyone adjusts to using the new electronic batch records system.

### Benefits of an EBR

There are many benefits to implementing an electronic batch record system in your biotech company. With an electronic system, all of your data is housed in one secure location, which makes it easy to track and monitor batches from start to finish. This not only saves time and money, but it also ensures that the batches are processed accurately and efficiently.

An electronic batch record system can also help you to reduce errors and improve quality control. By tracking each step of the production process, any issues are quickly found and saved.

### Future of EBRs

The future of electronic batch records is looking bright. With more and more biotech companies moving to electronic batch recording, the benefits are clear. Here are just a few of the ways electronic batch records can help:

- **Ease of Use**: Electronic batch record systems are designed for ease of use, making them simple to learn and operate.
- **Faster Updates**: With an electronic system, updates can be made quickly and easily, ensuring that your records are always up-to-date.
- **Accurate Records**: Electronic systems provide a precise and accurate record of each batch, ensuring that all information is accounted for.
- **Reliable Storage**: Records are stored electronically, meaning they are safe and secure.

Electronic batch records have revolutionised the way biotech companies operate, providing an efficient and reliable way to track and monitor batches of product. Read about Opvia’s EBR software  and sign up for a demo [here](https://www.opvia.io/contact).


Streamlining the batch record process with EBRs: a how-to guide for biotech companies

The food and beverage industry is one of the economy's largest industries globally generating millions of goods each day


The food and beverage industry is one of the economy's largest industries globally generating millions of goods each day. However the perishable nature of these products means that quality control throughout the supply chain is vital to avoid costly mistakes and product recalls.

![](media/screen-shot-2022-08-19-at-5.21.55-pm.png)

### Here are some benefits of using an EBR:

1. **Traceability:** This is imperative for manufacturers that produce products that contain allergens along with allergens-free versions in the same facility. Traceability controls within an EBR system are vital to ensuring no cross contamination occurs throughout the production process. The controls include the system enforcing the correct ingredients and packaging materials that are used for a specific batch of a product.

![](media/screen-shot-2022-08-19-at-5.22.44-pm.png)

1. **Compliance:** Regulatory compliance within the food industry is very stringent and constantly changing. Keeping up to date with these changes is easily done on a software solution that is more transparent and flexible. Changing guidelines are calling for greater transparency in the manufacturing processes. For example, the Federal Trade Commission is also set to set out new guidelines this year to make sure companies are more transparent with their processes along with also having reliable evidence for their claims. This is forcing manufacturing productions to rethink their supply chains and product life cycles. These guidelines can be better enforced and communicated using a digital solution. For example, the temperatures of perishable goods must be recorded throughout the stages of manufacturing and production and this can be better recorded and managed on an EBR.
2. **Stock Management:** Efficient management of perishable stock is vital when fresh ingredients reach the production stage. Features in an EBR such as batch-tracking, predictive stock management makes this easier and more sustainable without any wastage.
3. **Analysis:** Using an EBR, all the data is stored in a synchronous format which makes it easier to organise and analyse in the future. This analysis can be useful for optimization of the product or the manufacturing process.

The digitization of this process driven industry is paving way for necessary changes to ensure quality assurance and compliance which in turn reduce costs for the company.

Opvia’s no-code EBR solution is a simple yet effective solution that can be made to fit for various manufacturing processes in the F&B industry. Following from the points discussed in this article some features included are registries, electronic signatures, and the ability to easily connect data samples. Read more about Opvia’s solution .


Benefits of using an EBR in the food and beverage industry

L﻿earn how Opvia helps companies streamline and standardise their BOM operations

L﻿earn how Opvia helps companies streamline and standardise their BOM operations. 

The Bill of Materials (BOM) is a crucial component of a batch record, particularly in pharmaceutical manufacturing. It provides a comprehensive list of all the materials required to produce a specific batch of product. The BOM serves as a blueprint, guiding the production process and ensuring consistency, accuracy and quality throughout the manufacturing process.

BOMs are of utmost importance for GMP, especially for: 

* Accurate Inventory Management
* QC & Traceability
* Consistency and Standardisation
* Cost Control
* Regulatory Compliance
* Continuous Improvement & Process Optimization

By meticulously maintaining the BOM, manufacturing companies can uphold quality standards, meet regulatory requirements, optimise operations and deliver superior products with confidence. 

Harness the power of Opvia to revolutionise your BOM management and unlock a new level of efficiency and precision in your manufacturing operations.

<div style="position: relative; padding-bottom: calc(51.31707317073171% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/6b1ZpGFHYhacvIuqoxy6?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="Bill of Materials"></iframe></div>

Bill of Materials

Cell therapies are highly complex and personalised treatments, involving the manipulation and administration of living cells to patients

Cell therapies are highly complex and personalised treatments, involving the manipulation and administration of living cells to patients. 

Batch records serve as a detailed documentation of the entire manufacturing process, capturing critical information such as cell sourcing, cultivation, processing and quality control measures. These records provide a comprehensive overview of each batch, allowing for traceability, reproducibility and regulatory compliance. 

Quality Management Systems establish rigorous standards and processes to monitor and control various aspects of cell therapy manufacturing, including facility design, personnel training, raw material management and product testing. 

By adhering to stringent quality management practices and maintaining accurate batch records, manufacturers can identify and mitigate potential risks, ensure consistent product quality and ultimately enhance patient safety and therapeutic outcomes in the field of cell therapy. 

Opvia empowers manufacturing teams to easily create, manage and execute batch records digitally, ensuring accuracy, traceability and efficiency every step of the way. With its intuitive interface and customisable workflows, Opvia adapts to your needs, seamlessly integrating with existing Opvia solutions. 

Experience enhanced data integrity, real-time visibility and automated reporting, while reducing errors and compliance risks. Stay ahead in the competitive landscape with Opvia, your partner in driving operational excellence and maintaining GMP compliance effortlessly.

<div style="position: relative; padding-bottom: calc(51.24999999999999% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/xhKknfeR4yvmPmWCBqVW?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="Manufacturing Execution Records"></iframe></div>

Cell Therapy Manufacturing

It is estimated that ~1-5% of compounds pass the hit-to-lead identification process during discovery

It is estimated that ~1-5% of compounds pass the hit-to-lead identification process during discovery. Not only does the low transfer rate slow down discovery, but also adds a significant cost burden, especially to early stage start-ups. 

Biotechs around the globe are searching for ways of maximising their success rate to speed up development and minimise costs. 

One method of accelerating this discovery is through information centralisation.

Storing compounds in a well-structured and comprehensive database is of paramount importance to drug discovery companies. Such databases provide a powerful platform for managing and organising an array of chemical compounds and their data. 

By centralising this information, companies can enhance their R&D efforts by efficiently accessing and exploring compound data, facilitating faster hit-to-lead decision-making and accelerating the discovery of novel therapeutic candidates. 

## Build a custom database to manage your assets on Opvia

Opvia’s intuitive and flexible interface allows trailblazing drug-discovery teams to seamlessly aggregate and display the information of choice of a compound library, including chemical structures, inventory information and assay / study data from every step of the development and manufacturing pipeline. 

Opvia transforms the drug discovery landscape, enabling companies to rapidly identify promising candidates and ultimately accelerate the discovery process. 

<div style="position: relative; padding-bottom: calc(51.388888888888886% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/xrMQIrCyevgzrNSRDuLf?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="Compound Management"></iframe></div>

Compound Management

Testing dose responses from candidate compounds play a crucial role in pharmaceutical research and development, as well as in clinical practice

Testing dose responses from candidate compounds play a crucial role in pharmaceutical research and development, as well as in clinical practice. They help us understand the potency and efficacy of a drug, optimising dosing regiments and ensuring patient safety.

By evaluating the relationship between dose and response, researchers can gain valuable insights into the therapeutic effects of a hit compound. 

The dose-response relationship explores how the concentration of a drug influences its biological response or effect. It involves exposing cells to various concentrations of a drug and measuring the biological or physiological response. This process helps identify the optimal drug concentration or dosage range that produces the desired therapeutic effect whilst minimising any potential adverse effects. 

Determining the EC50 is a fundamental outcome of dose-response analysis. The EC50 represents the concentration of a drug required to produce a halfway response between the baseline and maximum effect. It serves as a quantitative measure of the potency. 

Opvia simplifies the process of running primary screening assays, enabling instant visualisation of dose-response curves and auto-determination of EC50s, making it an indispensable tool in the field of drug discovery. With Opvia, comparing candidate compounds during primary screening becomes effortless and efficient.

Determining EC50s

In the field of drug discovery, the identification and development of novel compounds with desired pharmacological properties is a complex and challenging task

In the field of drug discovery, the identification and development of novel compounds with desired pharmacological properties is a complex and challenging task. One crucial aspect of this process involves comparing the EC50 (half-maximal effective concentration) and LogP (octanol-water partition coefficient) values for various candidate compounds. This comparative analysis plays a significant role in evaluating the potential of these compounds and determining their suitability for further development.

The EC50 value represents the concentration of a compound required to achieve a response halfway between baseline and maximum effect. It is commonly used to measure the potency or efficacy of a drug candidate. By comparing the EC50 values of different compounds, drug discovery scientists can gain insights into their relative potency and select the most promising candidates for further investigation. Compounds with lower EC50 values are generally considered more potent, as they require lower concentrations to produce the desired therapeutic effect.

On the other hand, LogP is a measure of the compound's lipophilicity, indicating its ability to dissolve in lipids or fats. It represents the logarithm of the ratio of a compound's concentration in the organic phase (usually octanol) to its concentration in the aqueous phase (usually water). LogP is an essential physicochemical parameter in drug discovery, as it influences the compound's absorption, distribution, metabolism, and excretion (ADME) properties. Compounds with appropriate LogP values are more likely to possess favorable pharmacokinetic characteristics, allowing for better tissue penetration, optimal distribution, and increased bioavailability.

When comparing EC50 and LogP values for candidate compounds, drug discovery scientists can draw important conclusions regarding their potential therapeutic efficacy and drug-likeness. Ideally, an effective drug candidate should possess both desirable potency (low EC50) and appropriate lipophilicity (optimal LogP). A compound with a low EC50 and balanced LogP value suggests a higher likelihood of achieving the desired pharmacological effect at a lower dosage, which can lead to reduced toxicity and improved patient compliance.

Moreover, comparing EC50 and LogP values is crucial for making informed decisions during the lead optimization phase. Drug discovery companies often encounter multiple candidate compounds with varying potencies and lipophilicities. Through careful analysis and comparison of these parameters, scientists can prioritize compounds that exhibit a favorable balance between potency and lipophilicity. This comparative evaluation ensures that the selected compounds have a higher likelihood of success during subsequent stages of development, such as in vivo studies, safety evaluations, and clinical trials.

<div style="position: relative; padding-bottom: calc(51.31944444444444% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/yxgZAv3iTesFdYjzBoas?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="EC50 vs. LogP"></iframe></div>

EC50 v LogP

Hormones play a critical role in regulating various physiological processes and maintaining homeostasis in the body

Hormones play a critical role in regulating various physiological processes and maintaining homeostasis in the body. By assessing the impact of drug compounds on hormone levels, researchers can gain insights into the compound’s potential effects on endocrine function, hormonal balance and overall health. This information is crucial for evaluating the safety, efficacy and potential side effects, as well as for developing targeted therapies for hormone-related disorders.

Opvia empowers researchers with the ability to effortlessly aggregate data from animal studies and automate plotting and analysis. Through centralising data in one database, researchers can instantly uncover valuable insights, identify trends and make informed decisions with confidence.

<div style="position: relative; padding-bottom: calc(51.31944444444444% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/H97dsMCOf3SwWFZrQacN?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="In Vitro Animal Studies"></iframe></div>

Endocrine In Vivo Studies

Capturing and comparing bioreactor data plays a pivotal role in the success of biotechnology firms, as it offers them a wealth of valuable information to optimize their processes, ensure stringent quality control, and drive continuous innovation

Capturing and comparing bioreactor data plays a pivotal role in the success of biotechnology firms, as it offers them a wealth of valuable information to optimize their processes, ensure stringent quality control, and drive continuous innovation. The ability to monitor and analyze critical parameters such as temperature, pH, dissolved oxygen levels, nutrient concentrations, and cell growth in real-time provides deep insights into the performance of bioreactors and the overall bioprocess.

By capturing bioreactor data, companies gain a comprehensive understanding of the dynamic conditions within the system, enabling them to detect subtle changes, identify trends, and make informed decisions promptly. This data-driven approach facilitates the identification of optimal process parameters, leading to enhanced productivity, improved product quality, and reduced production costs.

However, managing and analyzing large volumes of bioreactor data can be a daunting task. That's where our powerful software comes into play. The Opvia Cloud Platform simplifies the data capture process, enabling biotechnology firms to effortlessly collect and store data from multiple bioreactors in a centralized database. With intuitive data visualization and analysis tools, The Opvia Cloud Platform empowers researchers and engineers to efficiently explore and compare data sets, uncover patterns, and gain actionable insights.

The software's advanced analytical capabilities allow for run-to-run comparisons, statistical analysis, and trend identification, which are essential for process optimization and troubleshooting. It enables biotechnologists to pinpoint process inefficiencies, identify bottlenecks, and optimize critical parameters to maximize yield and productivity. Moreover, the software facilitates rapid detection of anomalies or deviations, triggering timely corrective actions to maintain process integrity and product quality.

Cellular Agriculture

Bioreactor Data Capture

In-process testing is one of the most important element in the manufacturing process

In-process testing is one of the most important element in the manufacturing process. It is critical to ensuring that products meet quality standards throughout the manufacturing process. 

By testing products at various stages of production, manufacturers can identify issues early on and make adjustments to prevent defects from occurring later in the process. This can save time and money by reducing the need for rework and minimising the risk of product recalls.

Explore how Opvia enables visibility across QC testing of process samples.

Opvia is a powerful tool that enables visibility across QC testing of process samples - it enables you to build comprehensive dashboards that allows you to view all of your process samples at a glance. With Opvia, you can easily track the status of each sample, monitor progress, and ensure that all tests are completed on time.

Opvia also provides detailed analytics and reporting tools, allowing you to identify trends and patterns in your testing data. By streamlining your QC experiments into one platform, you are also able to quickly generate reports for internal review or send to customers, if needed.

In Process Testing 

In-vitro ADME PK studies play a critical role in drug discovery

In-vitro ADME PK studies play a critical role in drug discovery. These studies involve the use of laboratory techniques to investigate how a drug candidate is absorbed, distributed, metabolised and eliminated within a living organism.

By assessing these pharmacokinetic properties early in the drug development process, researchers can gain valuable insights into the drug’s behaviour, efficacy and safety profile. In-vitro ADME PK studies help identify potential issues related to drug absorption, metabolism, drug-drug interactions and toxicity allowing scientists to make informed decisions about drug candidates and optimise their properties for proceeding with further studies.

Managing, analysing and visualising drug stability data across different species is of paramount importance in drug development. Understanding the stability of a drug candidate across various species provides critical insights into its behaviour, degradation pathways and potential adverse effects. 

Visualising this data through graphical representations helps in interpreting complex stability information and aids in decision-making during pre-clinical development, ultimately ensuring the safety and efficacy of the drug in diverse patient populations. 

Opvia empowers you to unlock the true potential of your drug stability data through instant insights, revolutionising the way you navigate the complexities of drug development.

<div style="position: relative; padding-bottom: calc(51.24999999999999% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/l0sBKkRLIFPxumxe39oQ?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="ADME PK Stability Studies"></iframe></div>

ADME PK Studies

Tracking different media formulations and their impact on product quality and cell growth is essential for biotechnology firms

Tracking different media formulations and their impact on product quality and cell growth is essential for biotechnology firms. The composition of growth media significantly influences bioprocess performance, including growth rate, product yield, and overall product quality. The Opvia Cloud Platform empowers firms by providing a user-friendly solution to easily track and analyze various media formulations. It enables comprehensive data recording, organization, and visualization, allowing researchers to identify optimal combinations of nutrients, supplements, and growth factors for maximizing productivity and ensuring consistent quality.

With The Opvia Cloud Platform, teams can efficiently capture and store data on media compositions, growth parameters, and quality metrics. Use intuitive data visualization and analysis tools help uncover trends and correlations, enabling valuable insights into the impact of different media formulations. By streamlining data collection and analysis, Opvia eliminates manual record-keeping, reduces errors, and saves time and resources. It facilitates informed decision-making, accelerates the optimization of media formulations, and streamlines process development, ultimately leading to improved product quality, increased yields, and reduced time-to-market.

Additionally, The Opvia Cloud Platform supports knowledge sharing and collaboration between teams. It establishes comprehensive databases of media formulations and their performance data, enabling easy access to historical records and facilitating comparisons between experiments. This enhances research efficiency, promotes data-driven innovation, and enables faster iteration cycles. By leveraging the power of The Opvia Cloud Platform, biotechnology firms can harness the potential of data-driven optimization, driving advancements in bioprocesses and accelerating the development of high-quality biotech products.

Media Formulation

Good sample management practices play a critical role in the success of biotechnology companies

Good sample management practices play a critical role in the success of biotechnology companies. Samples, including cell cultures, biomolecules, and experimental data, are invaluable assets that hold crucial information for research, development, and quality control processes. Effective sample management ensures sample integrity, traceability, and accessibility, facilitating accurate data interpretation, reproducibility, and regulatory compliance. By implementing robust sample management practices, biotechnology companies can safeguard their valuable resources, optimize workflows, and drive scientific advancements and innovation.

Opvia’s cutting-edge sample management software, empowers biotechnology companies to seamlessly implement and optimize their sample management practices. With Opvia, the complex task of handling diverse sample types and associated data becomes effortless, ensuring sample integrity and enhancing overall operational efficiency.

Opvia enables biotechnology companies to track and manage samples with precision. It offers a centralized and intuitive interface for sample registration, labeling, storage location tracking, and retrieval. The software's advanced search and barcode scanning capabilities simplify the process of locating and accessing samples, saving valuable time and minimizing the risk of sample misplacement or loss.

With Opvia, biotechnology companies can establish comprehensive sample repositories, capturing key information such as sample origin, preparation protocols, and storage conditions. This allows for complete traceability, ensuring compliance with regulatory standards and facilitating data reproducibility. The software also provides audit trails and user access controls to maintain data integrity and confidentiality.

Sample Management

Target Candidate Profiles play a pivotal role in drug discovery by guiding researchers in identifying and prioritising candidate drugs

Target Candidate Profiles play a pivotal role in drug discovery by guiding researchers in identifying and prioritising candidate drugs. These profiles outline the desired characteristics and properties of a compound. 

By establishing clear target candidate profiles, researchers can streamline the drug discovery process, focus their efforts on the most promising candidates and increase the chances of developing effective and safe drugs, quickly and cost-efficiently. 

Opvia automates result reporting for candidate compounds, unlocking a new level of efficiency and data insight. By consolidating and visualising data across the drug discovery pipeline, companies gain a comprehensive understanding of their candidates, enabling better informed decision-making, faster identification of promising candidates and the ability to allocate resources faster and more effectively. 

Opvia provides pharmaceutical companies with a competitive advantage to discover and deliver faster than ever before.

<div style="position: relative; padding-bottom: calc(51.24999999999999% + 41px); height: 0; width: 100%"><iframe src="https://demo.arcade.software/qAJdf2CXNtHkNLWcmEu8?embed" frameborder="0" loading="lazy" webkitallowfullscreen mozallowfullscreen allowfullscreen style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;color-scheme: light;" title="Target Candidate Profile"></iframe></div>

Target Candidate Profiles

See How Opvia's Platform Is Used For Pharmaceutical

Industries

Pharmaceutical

Data drives discovery.Build on a strong foundation of structured data.

Request consultation